Power3 Medical Products' Dr. Ira L. Goldknopf Stated in an Interview That the Company Plans to Completely and Strategically Reposition Itself Through a Consolidation of Stem Cell, Diagnostic, and Therapeutic Companies and Intellectual Property

Published: May 07, 2010

HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB: PWRM) today announced that the company has targeted several key acquisition candidates that own or have exclusive rights to market certain complementary assets and technologies that will enhance its intellectual property portfolio. Power3 intends to evaluate opportunities that can provide it with, among other things, promising stem cell research, patents and other intellectual property assets, new technologies, and key personnel or capabilities, that could augment these efforts.

Back to news